Association between moderate renal insufficiency and cardiovascular events in a general population: Tehran lipid and glucose study

BMC Nephrology

Volumn 13, Issue 1, 2012, Pages

  Hosseinpanah, Farhad ^a   Barzin, Maryam ^a   Golkashani, Hosein Aghayan ^a   Nassiri, Amir A ^a   Sheikholeslami, Farhad ^b   Azizi, Fereidoun ^c  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Body mass index; Cardiovascular disease; Chronic kidney disease; General population; Glomerular filtration rate

Indexed keywords

CHOLESTEROL; CREATININE; TRIACYLGLYCEROL; LIPID;

ADULT; ARTICLE; BODY MASS; BODY WEIGHT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CIGARETTE SMOKING; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; SYSTOLIC BLOOD PRESSURE; AGED; BLOOD; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; GLUCOSE BLOOD LEVEL; HEALTH SURVEY; IRAN; METABOLISM; METHODOLOGY; MIDDLE AGED; PHYSIOLOGY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR;

ADULT; AGED; BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; IRAN; LIPIDS; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY; RISK FACTORS;

EID: 84864695054     PISSN: None     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/1471-2369-13-59     Document Type: Article

References (38)

1. Excerpts from the US Renal Data System 2009 Annual Data Report. Collins AJ, Foley RN, Herzog C, Chavers BM, Gilbertson D, Ishani A, Kasiske BL, Liu J, Mau LW, McBean M, Murray A, St Peter W, Guo H, Li Q, Li S, Peng Y, Qiu Y, Roberts T, Skeans M, Snyder J, Solid C, Wang C, Weinhandl E, Zaun D, Arko C, Chen SC, Dalleska F, Daniels F, Dunning S, Ebben J, et al. Am J Kidney Dis 2010 55 1 420 A426-427 10.1053/j.ajkd.2009.10.005 20053342
2. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, McCullough PA, Kasiske BL, Kelepouris E, Klag MJ, Parfrey P, Pfeffer M, Raij L, Spinosa DJ, Wilson PW, Circulation 2003 108 2154 2169 10.1161/01.CIR.0000095676.90936.80 14581387 (Pubitemid 37337595)
3. Cardiac diseases in maintenance hemodialysis patients: results of the HEMO Study. Cheung AK, Sarnak MJ, Yan G, Berkoben M, Heyka R, Kaufman A, Lewis J, Rocco M, Toto R, Windus D, Ornt D, Levey AS, Kidney Int 2004 65 2380 2389 10.1111/j.1523-1755.2004.00657.x 15149351 (Pubitemid 38670024)
4. Traditional cardiovascular disease risk factors in dialysis patients compared with the general population: the CHOICE Study. Longenecker JC, Coresh J, Powe NR, Levey AS, Fink NE, Martin A, Klag MJ, J Am Soc Nephrol 2002 13 1918 1927 10.1097/01.ASN.0000019641.41496.1E 12089389 (Pubitemid 34700618)
5. The obesity paradox and mortality associated with surrogates of body size and muscle mass in patients receiving hemodialysis. Kalantar-Zadeh K, Streja E, Kovesdy CP, Oreopoulos A, Noori N, Jing J, Nissenson AR, Krishnan M, Kopple JD, Mehrotra R, Anker SD, Mayo Clin Proc 2010 85 991 1001 10.4065/mcp.2010.0336 21037042
6. Level of kidney function as a risk factor for cardiovascular outcomes in the elderly. Manjunath G, Tighiouart H, Coresh J, Macleod B, Salem DN, Griffith JL, Levey AS, Sarnak MJ, Kidney Int 2003 63 1121 1129 10.1046/j.1523-1755.2003. 00838.x 12631096 (Pubitemid 36315592)
7. Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999. Foley RN, Murray AM, Li S, Herzog CA, McBean AM, Eggers PW, Collins AJ, J Am Soc Nephrol 2005 16 489 495 10.1681/ASN.2004030203 15590763 (Pubitemid 41725146)
8. Association of kidney function and albuminuria with cardiovascular mortality in older vs younger individuals: The HUNT II Study. Hallan S, Astor B, Romundstad S, Aasarod K, Kvenild K, Coresh J, Arch Intern Med 2007 167 2490 2496 10.1001/archinte.167.22.2490 18071172 (Pubitemid 350254909)
9. Independent components of chronic kidney disease as a cardiovascular risk state: results from the Kidney Early Evaluation Program (KEEP). McCullough PA, Jurkovitz CT, Pergola PE, McGill JB, Brown WW, Collins AJ, Chen SC, Li S, Singh A, Norris KC, Klag MJ, Bakris GL, Arch Intern Med 2007 167 1122 1129 10.1001/archinte.167.11.1122 17563019 (Pubitemid 46919814)
10. How does minor renal dysfunction influence cardiovascular risk and the management of cardiovascular disease? Pinkau T, Hilgers KF, Veelken R, Mann JF, J Am Soc Nephrol 2004 15 517 523 10.1097/01.ASN.0000107565.17553.71 14978153 (Pubitemid 38294781)
11. Coronary atherosclerosis detected by coronary CT angiography in asymptomatic subjects with early chronic kidney disease. Cho I, Min HS, Chun EJ, Park SK, Choi Y, Blumenthal RS, Rivera JJ, Nasir K, Kim YJ, Sohn DW, Oh BH, Park YB, Chang HJ, Atherosclerosis 2010 208 406 411 10.1016/j.atherosclerosis. 2009.08.040 19781704
12. Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency. Culleton BF, Larson MG, Wilson PW, Evans JC, Parfrey PS, Levy D, Kidney Int 1999 56 2214 2219 10.1046/j.1523-1755.1999.00773.x 10594797 (Pubitemid 30004750)
13. Moderate renal insufficiency and the risk of cardiovascular mortality: results from the NHANES I. Garg AX, Clark WF, Haynes RB, House AA, Kidney Int 2002 61 1486 1494 10.1046/j.1523-1755.2002.00270.x 11918756 (Pubitemid 34304510)
14. High prevalence of chronic kidney disease in Iran: a large population-based study. Hosseinpanah F, Kasraei F, Nassiri AA, Azizi F, BMC Public Health 2009 9 44 10.1186/1471-2458-9-44 19183493
15. Prevention of non-communicable disease in a population in nutrition transition: Tehran Lipid and Glucose Study phase II. Azizi F, Ghanbarian A, Momenan AA, Hadaegh F, Mirmiran P, Hedayati M, Mehrabi Y, Zahedi-Asl S, Trials 2009 10 5 10.1186/1745-6215-10-5 19166627
16. Association of total cholesterol versus other serum lipid parameters with the short-term prediction of cardiovascular outcomes: Tehran Lipid and Glucose Study. Hadaegh F, Harati H, Ghanbarian A, Azizi F, Eur J Cardiovasc Prev Rehabil 2006 13 571 577 10.1097/01.hjr.0000216552.81882.ca 16874147 (Pubitemid 44162159)
17. Stone NJ: Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Grundy SM, Cleeman JI, Merz CN, Brewer HB, Clark LT, Hunninghake DB, Pasternak RC, Smith SC, Circulation 2004 110 227 239 10.1161/01.CIR.0000133317.49796.0E 15249516 (Pubitemid 38924592)
18. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003 26 1 5 20
19. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). Kobe B, JAMA 2001 285 2486 2497 10.1001/jama.285.19.2486 11368702
20. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D, Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999 130 461 470 (Pubitemid 29135798)
21. evaluation, classification, and stratification. K/DOQI clinical practice guidelines for chronic kidney disease, Am J Kidney Dis 2002 39 1 266 11904577
22. Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. Weiner DE, Tighiouart H, Amin MG, Stark PC, MacLeod B, Griffith JL, Salem DN, Levey AS, Sarnak MJ, J Am Soc Nephrol 2004 15 1307 1315 10.1097/01.ASN.0000123691.46138.E2 15100371 (Pubitemid 38526012)
23. Chronic kidney disease and mortality risk: a systematic review. Tonelli M, Wiebe N, Culleton B, House A, Rabbat C, Fok M, McAlister F, Garg AX, J Am Soc Nephrol 2006 17 2034 2047 10.1681/ASN.2005101085 16738019 (Pubitemid 44036188)
24. Mild renal insufficiency is associated with increased cardiovascular mortality: The Hoorn Study. Henry RM, Kostense PJ, Bos G, Dekker JM, Nijpels G, Heine RJ, Bouter LM, Stehouwer CD, Kidney Int 2002 62 1402 1407 10.1111/j.1523-1755.2002.kid571.x 12234312
25. The glomerular filtration rate in an apparently healthy population and its relation with cardiovascular mortality during 10years. Van Biesen W, De Bacquer D, Verbeke F, Delanghe J, Lameire N, Vanholder R, Eur Heart J 2007 28 478 483 10.1093/eurheartj/ehl455 17223665 (Pubitemid 47343557)
26. Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community. Manjunath G, Tighiouart H, Ibrahim H, MacLeod B, Salem DN, Griffith JL, Coresh J, Levey AS, Sarnak MJ, J Am Coll Cardiol 2003 41 47 55 12570944 (Pubitemid 36044403)
27. Screening strategies for chronic kidney disease in the general population: follow-up of cross sectional health survey. Hallan SI, Dahl K, Oien CM, Grootendorst DC, Aasberg A, Holmen J, Dekker FW, BMJ 2006 333 1047 10.1136/bmj.39001.657755.BE 17062598 (Pubitemid 44807817)
28. Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States. Muntner P, He J, Hamm L, Loria C, Whelton PK, J Am Soc Nephrol 2002 13 745 753 11856780 (Pubitemid 34183941)
29. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY, N Engl J Med 2004 351 1296 1305 10.1056/NEJMoa041031 15385656 (Pubitemid 39268908)
30. Traditional and nontraditional risk factors predict coronary heart disease in chronic kidney disease: results from the atherosclerosis risk in communities study. Muntner P, He J, Astor BC, Folsom AR, Coresh J, J Am Soc Nephrol 2005 16 529 538 10.1681/ASN.2004080656 15625072 (Pubitemid 41725151)
31. Nontraditional risk factors for cardiovascular disease in patients with chronic kidney disease. Kendrick J, Chonchol MB, Nat Clin Pract Nephrol 2008 4 672 681 10.1038/ncpneph0954 18825155
32. Chronic kidney disease: effects on the cardiovascular system. Schiffrin EL, Lipman ML, Mann JF, Circulation 2007 116 85 97 10.1161/CIRCULATIONAHA.106. 678342 17606856 (Pubitemid 47016250)
33. Drawbacks of the use of indirect estimates of renal function to evaluate the effect of risk factors on renal function. Verhave JC, Gansevoort RT, Hillege HL, De Zeeuw D, Curhan GC, De Jong PE, J Am Soc Nephrol 2004 15 1316 1322 15100372 (Pubitemid 38526013)
34. A comparison of prediction equations for estimating glomerular filtration rate in adults without kidney disease. Lin J, Knight EL, Hogan ML, Singh AK, J Am Soc Nephrol 2003 14 2573 2580 10.1097/01.ASN.0000088721.98173.4B 14514734 (Pubitemid 37169342)
35. Why the MDRD equation should not be used in patients with normal renal function (and normal creatinine values)? Delanaye P, Cavalier E, Krzesinski JM, Chapelle JP, Clin Nephrol 2006 66 147 148 16939074 (Pubitemid 44219444)
36. Fact or fiction of the epidemic of chronic kidney disease-let us not squabble about estimated GFR only, but also focus on albuminuria. de Jong PE, Gansevoort RT, Nephrol Dial Transplant 2008 23 1092 1095 18359868 (Pubitemid 351767532)
37. Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Hillege HL, Fidler V, Diercks GF, van Gilst WH, de Zeeuw D, van Veldhuisen DJ, Gans RO, Janssen WM, Grobbee DE, de Jong PE, Circulation 2002 106 1777 1782 10.1161/01.CIR.0000031732.78052.81 12356629
38. Cross-classification of microalbuminuria and reduced glomerular filtration rate: associations between cardiovascular disease risk factors and clinical outcomes. Foster MC, Hwang SJ, Larson MG, Parikh NI, Meigs JB, Vasan RS, Wang TJ, Levy D, Fox CS, Arch Intern Med 2007 167 1386 1392 10.1001/archinte.167.13.1386 17620532 (Pubitemid 47052437)